Diagnostic Value of Novel Presepsin and Inflammatory Biomarkers in Predicting the Clinical Course of COVID-19
Aim:The diagnostic value of inflammatory markers to determine the severity of Coronavirus disease-2019 (COVID-19) is postulated in some recent studies, but conclusions were inconsistent. Hence, we intend to examine the utility of presepsin, procalcitonin and C-reactive protein in predicting the severity of COVID-19 infection.Methods:Single-center cross-sectional study was undertaken at the Intensive care unit of a university hospital. Eighty consecutive cases diagnosed with Severe Acute Respiratory syndrome-Coronavirus-2 RNA between October 2020 and July 2021 were classified according to the severity of the disease. Laboratory data related to Procalcitonin and C-reactive protein was retrieved from investigations coinciding with the day of admission. The stored plasma was subjected to an enzyme-linked immunosorbent assay to determine plasma presepsin levels. Statistical test for measures of screening was employed and a receiver operator curve was generated.Results:We have determined that presepsin is the most sensitive prognostic indicator (93.3%) with a strong statistical association (p<0.001) for COVID-19. 15.99 ng/L could be used as a reference level to predict the progressive clinical course. Relatively lower sensitivity (88%) and positive statistical correlation (p=0.049) of C-reactive protein with high-risk infection were also observed. Procalcitonin showed limited diagnostic and prognostic value in our series.Conclusion:Our findings seem to demonstrate the role of presepsin in providing prognostic information in COVID-19 patients. Therefore, we suggest that early monitoring of presepsin with routine marker profile might help in identifying patients suffering from a more severe disease..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:59 |
|---|---|
| Enthalten in: |
Haseki Tıp Bülteni - 59(2021), 5, Seite 358-362 |
| Sprache: |
Englisch ; Türkisch |
|---|
| Beteiligte Personen: |
Faraz Hasan Mirza [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Biomarkers |
|---|
| doi: |
10.4274/haseki.galenos.2021.7653 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ052302105 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ052302105 | ||
| 003 | DE-627 | ||
| 005 | 20230310183903.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4274/haseki.galenos.2021.7653 |2 doi | |
| 035 | |a (DE-627)DOAJ052302105 | ||
| 035 | |a (DE-599)DOAJ9d4219592394407cb0f2a8e5a37d93b8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a tur | ||
| 050 | 0 | |a R5-920 | |
| 100 | 0 | |a Faraz Hasan Mirza |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Diagnostic Value of Novel Presepsin and Inflammatory Biomarkers in Predicting the Clinical Course of COVID-19 |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Aim:The diagnostic value of inflammatory markers to determine the severity of Coronavirus disease-2019 (COVID-19) is postulated in some recent studies, but conclusions were inconsistent. Hence, we intend to examine the utility of presepsin, procalcitonin and C-reactive protein in predicting the severity of COVID-19 infection.Methods:Single-center cross-sectional study was undertaken at the Intensive care unit of a university hospital. Eighty consecutive cases diagnosed with Severe Acute Respiratory syndrome-Coronavirus-2 RNA between October 2020 and July 2021 were classified according to the severity of the disease. Laboratory data related to Procalcitonin and C-reactive protein was retrieved from investigations coinciding with the day of admission. The stored plasma was subjected to an enzyme-linked immunosorbent assay to determine plasma presepsin levels. Statistical test for measures of screening was employed and a receiver operator curve was generated.Results:We have determined that presepsin is the most sensitive prognostic indicator (93.3%) with a strong statistical association (p<0.001) for COVID-19. 15.99 ng/L could be used as a reference level to predict the progressive clinical course. Relatively lower sensitivity (88%) and positive statistical correlation (p=0.049) of C-reactive protein with high-risk infection were also observed. Procalcitonin showed limited diagnostic and prognostic value in our series.Conclusion:Our findings seem to demonstrate the role of presepsin in providing prognostic information in COVID-19 patients. Therefore, we suggest that early monitoring of presepsin with routine marker profile might help in identifying patients suffering from a more severe disease. | ||
| 650 | 4 | |a sars-cov-2 patients | |
| 650 | 4 | |a biomarkers | |
| 650 | 4 | |a presepsin | |
| 650 | 4 | |a prognosis | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 653 | 0 | |a Medicine (General) | |
| 700 | 0 | |a Faraz Ahmed Baig |e verfasserin |4 aut | |
| 700 | 0 | |a Serajuddaula Syed |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Haseki Tıp Bülteni |d Galenos Yayinevi, 2015 |g 59(2021), 5, Seite 358-362 |w (DE-627)DOAJ00012513X |x 21472688 |7 nnns |
| 773 | 1 | 8 | |g volume:59 |g year:2021 |g number:5 |g pages:358-362 |
| 856 | 4 | 0 | |u https://doi.org/10.4274/haseki.galenos.2021.7653 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/9d4219592394407cb0f2a8e5a37d93b8 |z kostenfrei |
| 856 | 4 | 0 | |u http://www.hasekidergisi.com/archives/archive-detail/article-preview/diagnostic-value-of-novel-presepsin-and-nflammator/49790 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1302-0072 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2147-2688 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 59 |j 2021 |e 5 |h 358-362 | ||